Loading...
Internationally Recognized Certificates of Compliance (IRCC)
  |  
last updated: 05 Apr 2016
General Information
ABSCH-IRCC-IN-206810-1
- Competent National Authority: | ABSCH-CNA-IN-202013-2
Competent National Authority:
National Biodiversity Authority ()
5th Floor, TICEL Biopark, CSIR Road, Taramani
Chennai, Tamilnadu
600 113, India
Phone: +91 44 2254 2777,
Fax: +91 44 2254 1200,
Details of the permit or its equivalent
India/NBA/Appl/9/790

Application in Form-III for seeking approval for the invention "Process for extraction of bio-active compounds exhibiting anticancer property from Lentinus tuberregium"  for obtaining IP Rights in India 

19 Jan 2016
Prior Informed Consent (PIC) Information
Yes
- Competent National Authority: | ABSCH-CNA-IN-202013-2
Competent National Authority:
National Biodiversity Authority ()
5th Floor, TICEL Biopark, CSIR Road, Taramani
Chennai, Tamilnadu
600 113, India
Phone: +91 44 2254 2777,
Fax: +91 44 2254 1200,
Confidential information
- Organization: University of Madras (UM) | ABSCH-CON-IN-207066-1
Organization:
University of Madras (UM)
Academic or research institute
Dr V. Kaviyarasan
Assistant Professor, Centre for Advanced Studies in Botany
Guindy Campus,
Chennai, Chennai
600 021, India
Phone: +91 44 25399422,
Fax:
Website:
Confidential information
Mutually Agreed Terms (MAT) Information
Yes
1. The user shall notify the NBA on the grant of IPR within 30 days from the grant.

2. If the user himself commercializes the process/product/innovation, the monetary sharing shall be 0.2% on the annual gross ex-factory sale minus government taxes.

3. The user needs to inform the NBA about any commercialization made on the IP Rights granted .

4. The user shall submit the half-yearly report to NBA as per the terms and conditions agreed upon.  

Subject-matter or genetic resource(s)
For obtaining the IP Rights on the  invention "Process for extraction of bio-active compounds exhibiting anticancer property from Lentinus tuberregium" in India
Confidential information
Information on the utilization of the genetic resource(s)
  • Commercial
1. If the user assigns/licenses the process/product/innovation to a third party for commercialization, the user shall pay to NBA 3.0% of the fee received (in any form including the license / assignee fee) and 2.0% of the royalty amount received annually from the assignee/licensee. 

2. In case the user assigns or transfer the IPR in whole or in part to any person, whether voluntarily or involuntarily, the user undertakes to attach this agreement as an appendix to the assignment instrument.   

Additional Information
Amendment history
Unique identifier Status Date
ABSCH-IRCC-IN-206810-1
REVOKED OLD VERSION PUBLISHED DELETED
Hem Pande (hempande@nic.in)
05 Apr 2016 10:43
on 05 Apr 2016 10:43
Loading...